Clinical Study for the Evaluation of the Depigmenting Activity of a Cosmetic Product on Spotted Hand Skin
1 other identifier
interventional
22
1 country
1
Brief Summary
Aim of the study was to evaluate by instrumental measurements the depigmenting activity of a cosmetic treatment for spotted hand skin; in particular it was investigated the synergic activity of an emulsion, with clarifying-antioxidant activity combined with an activator gel, with hydration and keratolytic activity. Female healthy volunteers aged 45-65 years old, presenting senile lentigo on the hands, were included in the study. It was also aim of this study to evaluate treatment efficacy and cosmetic acceptability by the volunteers and tolerance both by investigator and volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 healthy
Started Nov 2013
Shorter than P25 for phase_3 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 18, 2014
CompletedFirst Posted
Study publicly available on registry
July 30, 2014
CompletedJuly 30, 2014
March 1, 2014
2 months
July 18, 2014
July 29, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Skin spots image analysis: change from baseline (T2, T4 and T8 vs. T0)
Skin spots area was measured on the pre-selected images performed with or without Wood's lamp. The measure of skin spots area was performed by means of an image analysis software, with a function called "magic wand". Based on the colour similarities or on the difference of intensity ranges between the selected pixels (with a specified tolerance interval) the magic wand automatically traced the outline of the spot and measured the selected area (pixel2).
after 2, 4 and 8-week-treatment
Secondary Outcomes (2)
Spectrophotometric evaluation: change from baseline (T2, T4 and T8 vs. T0)
after 2, 4 and 8-week-treatment
Optical colorimetry: change from baseline (T2, T4 and T8 vs. T0)
after 2, 4 and 8 week-treatment
Study Arms (1)
Emulsion and gel
OTHERA fixed similar quantity of both emulsion and gel were applied consequentially on the hand twice a day, in the morning and in the evening (preferentially always at the same hour), with a mild massage, until complete absorption, for 8 weeks.
Interventions
A fixed similar quantity of both emulsion and gel were applied consequentially on the hand twice a day, in the morning and in the evening (preferentially always at the same hour), with a mild massage, until complete absorption, for 8 weeks.
Eligibility Criteria
You may qualify if:
- female healthy subjects
- age 45-65 years
- presence of moderate senile lentigo on the back of the hands
- accepting to not receive any drugs/cosmetic/chemical or physical treatment (peeling, intradermal implants etc.) able to change the skin characteristics during the entire duration of the study
- accepting to use the study product according to the instruction received by the investigator
- accepting not to expose to strong UV irradiation (UV session, or sun bathes) during the entire duration of the study
- subject agreeing not to use anti-spots products/treatments during the month preceding the test
- accepting to sign the Informed Consent Form
You may not qualify if:
- pregnancy
- lactation
- sensitivity to the test product or its ingredients
- subjects whose insufficient adhesion to the study protocol is foreseeable
- participation in a similar study actually or during the previous 3 months
- dermatological disease (dermatitis; presence of cutaneous disease on the tested area, as lesions, scars, malformations)
- clinical and significant skin condition on the test area (e.g. active eczema, dermatitis, psoriasis. etc.)
- diabetes
- endocrine disease
- hepatic disorder
- renal disorder
- cardiac disorder
- pulmonary disease
- cancer
- neurological or psychological disease
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Derming SRLlead
Study Sites (1)
DermIng SRL
Monza, Monza, 20900, Italy
Related Publications (18)
Asawanonda P, Taylor CR. Wood's light in dermatology. Int J Dermatol. 1999 Nov;38(11):801-7. doi: 10.1046/j.1365-4362.1999.00794.x. No abstract available.
PMID: 10583611BACKGROUNDAsserin J., Heusèle C., André P. , Preece S., Schnebert S. , Taieb A. Comparison of two techniques used in the evaluation of the depigmentation effect of cosmetic products on brown spots, 2004
BACKGROUNDClaridge E, Cotton S, Hall P, Moncrieff M. From colour to tissue histology: Physics-based interpretation of images of pigmented skin lesions. Med Image Anal. 2003 Dec;7(4):489-502. doi: 10.1016/s1361-8415(03)00033-1.
PMID: 14561553BACKGROUNDClaridge E, Preece SJ. An inverse method for the recovery of tissue parameters from colour images. Inf Process Med Imaging. 2003 Jul;18:306-17. doi: 10.1007/978-3-540-45087-0_26.
PMID: 15344467BACKGROUNDCurry AS, Gettings SD, McEwen GN CTFA safety testing guidelines. The Cosmetic, Toiletry and Fragrance Association, Washington, 1991
BACKGROUNDFernay, Voltaire The World Medical Association (1989) "World Medical Association Declaration of Helsinki", Hong-Kong
BACKGROUNDFullerton A, Fischer T, Lahti A, Wilhelm KP, Takiwaki H, Serup J. Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis. 1996 Jul;35(1):1-10. doi: 10.1111/j.1600-0536.1996.tb02258.x.
PMID: 8896947BACKGROUNDGilchrest BA, Fitzpatrick TB, Anderson RR, Parrish JA. Localization of malanin pigmentation in the skin with Wood's lamp. Br J Dermatol. 1977 Mar;96(3):245-8. doi: 10.1111/j.1365-2133.1977.tb06132.x.
PMID: 857837BACKGROUNDGupta LK, Singhi MK. Wood's lamp. Indian J Dermatol Venereol Leprol. 2004 Mar-Apr;70(2):131-5. No abstract available.
PMID: 17642589BACKGROUNDMatts Paul J., Carey Jeremy, Cotton Symon D. Chromophore Mapping: a New Technique to Characterize Aging Human Skin, In Vivo. American Academy of Dermatology 2005
BACKGROUNDMatts PJ, Dykes PJ, Marks R. The distribution of melanin in skin determined in vivo. Br J Dermatol. 2007 Apr;156(4):620-8. doi: 10.1111/j.1365-2133.2006.07706.x.
PMID: 17493065BACKGROUNDMoncrieff M, Cotton S, Claridge E, Hall P. Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. Br J Dermatol. 2002 Mar;146(3):448-57. doi: 10.1046/j.1365-2133.2002.04569.x.
PMID: 11952545BACKGROUNDRieger M.M., Battista G.W. Some experiences in the safety testing of cosmetics J. Soc. Cosmet. Chem. 15:161 -172 , 1964
BACKGROUNDRigano L. "Evaluation of the efficacy of a whitening product" ISPE Institute of Skin and Product Evaluation - March 15th 2007
BACKGROUNDSachs L. Applied statistics: a handbook of techniques Heidelberg: Springer, 1981:536-539
BACKGROUNDTaelman M-C, Dederen J. C. Relative performance testing of formulations: emulsifiers Cosmetics &Toiletries magazine August 2000; 115: 37-42
BACKGROUNDTakiwaki H. Measurement of skin color: practical application and theoretical considerations. J Med Invest. 1998 Feb;44(3-4):121-6.
PMID: 9597799BACKGROUNDZonios G, Bykowski J, Kollias N. Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. J Invest Dermatol. 2001 Dec;117(6):1452-7. doi: 10.1046/j.0022-202x.2001.01577.x.
PMID: 11886508BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adele Sparavigna, Doctor
Derming SRL
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2014
First Posted
July 30, 2014
Study Start
November 1, 2013
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
July 30, 2014
Record last verified: 2014-03